TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
+13.06%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$8.1B
AUM Growth
+$4.9B
(+153%)
Cap. Flow
+$4.52B
Cap. Flow
% of AUM
55.89%
Top 10 Holdings %
Top 10 Hldgs %
26.76%
Holding
6,444
New
508
Increased
3,437
Reduced
1,647
Closed
527
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$335M |
| 2 |
Apple
AAPL
|
+$258M |
| 3 |
Microsoft
MSFT
|
+$248M |
| 4 |
Amazon
AMZN
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$106M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$23.1M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$15.4M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$13.4M |
| 4 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$13.3M |
| 5 |
United States Oil Fund
USO
|
+$11.5M |
Sector Composition
| 1 | Technology | 26.16% |
| 2 | Financials | 11.28% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Seaboard Corp
SEB
$3.72B
| $107K | ﹤0.01% |
30
+24
| +400% | +$85.7K |
|
2602
Invesco MSCI USA ETF
PBUS
$8.74B
| $107K | ﹤0.01% |
+2,240
| New | +$107K |
|
2603
Rocket Pharmaceuticals
RCKT
$342M
| $107K | ﹤0.01% |
3,557
+1,829
| +106% | +$54.8K |
|
|
EVV
2604
Eaton Vance Limited Duration Income Fund
EVV
$1.19B
| $107K | ﹤0.01% |
11,127
+11,122
| +222,440% | +$107K |
|
|
ICVX
2605
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $106K | ﹤0.01% |
6,728
+4,546
| +208% | +$71.6K |
|
2606
First Financial Corporation Common Stock
THFF
$708M
| $106K | ﹤0.01% |
2,464
-10,584
| -81% | -$455K |
|
|
EGLE
2607
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $106K | ﹤0.01% |
1,913
-15,366
| -89% | -$851K |
|
2608
Twist Bioscience
TWST
$1.69B
| $106K | ﹤0.01% |
2,874
-3,103
| -52% | -$114K |
|
2609
Hercules Capital
HTGC
$3.52B
| $106K | ﹤0.01% |
6,345
+3,039
| +92% | +$50.7K |
|
2610
Turning Point Brands
TPB
$1.84B
| $106K | ﹤0.01% |
4,017
+3,419
| +572% | +$90K |
|
|
KRTX
2611
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $106K | ﹤0.01% |
334
-1,176
| -78% | -$372K |
|
2612
Children's Place
PLCE
$154M
| $106K | ﹤0.01% |
4,550
+4,335
| +2,016% | +$101K |
|
2613
Invesco S&P 500 Quality ETF
SPHQ
$15.4B
| $106K | ﹤0.01% |
1,952
+1,865
| +2,144% | +$101K |
|
|
CFB
2614
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $105K | ﹤0.01% |
7,765
+6,792
| +698% | +$92.2K |
|
|
DX
2615
Dynex Capital
DX
$1.61B
| $105K | ﹤0.01% |
8,378
+1,044
| +14% | +$13.1K |
|
|
ALPN
2616
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $105K | ﹤0.01% |
5,490
+4,417
| +412% | +$84.2K |
|
2617
CEMIG Preferred Shares
CIG
$5.98B
| $105K | ﹤0.01% |
58,577
-3,438
| -6% | -$6.14K |
|
2618
Ares Management
ARES
$40.2B
| $104K | ﹤0.01% |
877
-9,712
| -92% | -$1.15M |
|
2619
Cullinan Oncology
CGEM
$375M
| $104K | ﹤0.01% |
10,234
-5,156
| -34% | -$52.5K |
|
2620
Evolus
EOLS
$415M
| $104K | ﹤0.01% |
9,876
-1,732
| -15% | -$18.2K |
|
2621
Catalyst Pharmaceutical
CPRX
$2.5B
| $104K | ﹤0.01% |
6,184
+2,833
| +85% | +$47.6K |
|
2622
nCino
NCNO
$3.54B
| $104K | ﹤0.01% |
3,080
-1,977
| -39% | -$66.5K |
|
2623
Unisys
UIS
$290M
| $103K | ﹤0.01% |
18,415
+16,871
| +1,093% | +$94.8K |
|
2624
Spectrum Brands
SPB
$1.32B
| $103K | ﹤0.01% |
1,295
-667
| -34% | -$53.2K |
|
2625
Allient
ALNT
$810M
| $103K | ﹤0.01% |
3,411
+2,128
| +166% | +$64.3K |
|